Seroprevalence of herpes simplex virus type 2 infection among attendees of a sexually transmitted disease clinic in Italy

Sexually Transmitted Diseases

Volumn 27, Issue 5, 2000, Pages 292-295

  Cusini, Marco ^a   Cusan, Monica ^b   Parolin, Cristina ^b   Scioccati, Livia ^b   Decleva, Irene ^a   Mengoli, Carlo ^b   Suligoi, Barbara ^c   Palú, Giorgio ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGH RISK POPULATION; HUMAN; IMMUNOBLOTTING; ITALY; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; SEXUAL BEHAVIOR;

EID: 0034068750     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200005000-00011     Document Type: Article

References (36)

1. Corey L. Genital herpes. In: Holmes KK, Mardh PA, Sparling PF and Wiesner PJ, eds. Sexually Transmitted Diseases. 2nd ed. New York: McGraw Hill, 1990:391-413.
2. Cowan FM, Johnson AM, Ashley RL, Corel L, Mindel A. Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection. J Infect Dis 1996; 174:470-475.
3. Mindel A. Genital Herpes: the forgotten epidemic. J Herpes 1994; 1:39-48.
4. Koutsky LA, Stevens CE, Holmes KK, Ashley RL, Kiviat NB, Critchlow CW, Corey L. Underdiagnosis of genital herpes by current clinical and viral isolation procedures. N Engl J Med 1992; 326:1533-1539.
5. Ross JD, Smith IW, Elton RA. The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991. Genitourin Med 1993; 69:381-383.
6. Kroon S. Genital herpes: clinical disease, antiviral therapy and vaccines. Clin Infect Dis 1996; 3:391-414.
7. Schomogyi M, Wald A, Corey L. Herpes simplex virus-2 infection: an emerging disease? Infect Dis Clin North Am 1998; 12:47-61.
8. Ashley RL. Laboratory techniques in the diagnosis of herpes simplex infection. Genitourin Med 1993; 69:174-183.
9. Ashley RL, Wald A. Genital herpes: review of epidemic and potential use of type-specific serology. Clin Microbiol Rev 1999; 12:1-8.
10. Ashley RL. Type-specific Antibodies to HSV-1 and -2: Review of Methodology. HERPES 1998; 5:2.
11. Ashley RL, Eagleton M, Pfeiffer N. Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after-infection. J Clin Microbiol 1999 May; 37(5):1632-1633.
12. Ashley RL, Corey L. HSV type-specific antibody tests: patients are ready, are clinicians? Genitourin Med 1997; 73:235-236.
13. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Broors CA, Snowden CB. A. Seroepidemiological survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321:6-12.
14. Ades AE, Packham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989; 43:53-60.
15. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic. Demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis 1997; 24:149-155.
16. Halioua B, Malkin JE. Epidemiology of genital herpes recent advances. Eur J Dermatol 1999; 9:177-184.
17. Van de Laar MJW, Termorshuizen F, Slomka MJ, van Doornum GJJ, Ossewaarde JM, Brown DWG, Coutinho RA, van den Hoek JAR. Prevalence and correlates of herpes simplex virus type 2 infection: evaluation of behavioural risk factors. Int J Epidemiol 1998; 27:127-134.
18. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, St Louis ME. Herpes simplex virus type-2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
19. Cowan FM, Johnson AM, Ashley RL, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309:1325-1329.
20. Cunningham AL, Lee FK, Ho DW, Field PR, Law CL, Packham DR, McCrossin ID, Sjogren-Jansson E, Jeansson S, Nahmias AJ. Herpes simplex virus type-2 antibody in patients attending antenatal or STD clinics. Med J Aust 1993; 158:425-428.
21. Koutsky LA, Ashley RL, Holmes KK, Stevens CE, Critchlow CW, Kiviat N, Lipinski CM, Wolner-Hanssen P, Corey L. The frequency of unrecognized type-2 herpes simplex virus infection among women: implications for the control of genital herpes. Sex Transm Dis 1990; 17:90-94.
22. Corey L, Wald A. New developments in the biology of genital herpes. In: Sacks SL, Straus GE, Whitley RJ, Griffiths PD ed. Clinical management of herpes viruses. New York: Ios Press, 1995:43-45.
23. Suligoi B, Giuliani M, Binkin N. The national STD surveillance system in Italy: results of the first year of activity. STD Surveillance Working Group. Int J STD AIDS 1994; 5:93-100.
24. Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl 1990; 69:19-36.
25. Mele A, Franco E, Caprilli F, et al. Genital herpes infection in outpatients attending a sexually transmitted disease clinic in Italy. Eur J Epidemiol 1998; 4:386-388.
26. Groen J, Van Dijk G, Niesters HG, Van Der Meijden WI, Osterhaus AD. Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum. J Clin Microbiol 1998; 36:845-847.
27. Ashley RL, Wu L, Pickering JW, Tu MC, Schnorenberg L. Premarket evaluation of a commercial glycoprotein G-based enzyme immunoassay for herpes simplex virus type-specific antibodies. J Clin Microbiol 1998; 36:294-295.
28. Motulsky H. Intuitive Biostatistics. London: Oxford University Press, 1995.
29. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. Wiley Series in Probability and Mathematical Statistics. New York: John Wiley & Sons, 1981:212-222.
30. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955; 11:375-385.
31. Schmid DS, Brown DR, Nisenbaum R, Burke RL, Alexander D, Ashley RL, Pellett PE, Reeves WC. Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types 1 and 2. J Clin Microbiol 1999; 37:376-379.
32. Ashley RL, Cent A, Maggs V, Nahmias A, Corey L. Inability of enzyme immunoassay to discriminate between infections with herpes simplex virus type 1 and 2. Ann Intern Med 1991; 115:520-526.
33. Perkins NL, Coughlan EP, Franklin RA, Reid MR, Taylor J. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients. N Z Med J 1996; 109:402-405.
34. Christenson B, Bottiger M, Svensson A, Jeansson S. A 15-year surveillance study of antibodies to herpes simplex virus type 1 and 2 in a cohort of young girls. J Infect Dis 1992; 25:147-154.
35. Breining MK, Kingsley LA, Armstrong JA, Freeman DJ, Ho M. Epidemiology of genital herpes in Pittsburgh: serologic, sexual and racial correlates of apparent and inapparent herpes simplex infections. J Infect Dis 1990; 162:299-305.
36. Tabet SR, Krone MR, Paradise MA, Corey L, Stamm WE, Celum CL. Incidence of HIV and sexually transmitted diseases (STD) in a cohort of HIV-negative men who have sex with men (MSM). AIDS 1998; 12:2041-2048.